Patents by Inventor Nicola Burgess

Nicola Burgess has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230046828
    Abstract: This invention provides polypeptides represented by the following formula: H2N-A-X—B-A-X—B—HOOC which are based on HMGB1 as well as compositions comprising, and treatment methods using, such polypeptide.
    Type: Application
    Filed: May 12, 2022
    Publication date: February 16, 2023
    Inventors: Jagdeep Nanchahal, Alvaro Vinals Guitart, Wyatt Yue, Nicola Burgess-Brown, Tzung Yuan Lee, Ana Isabel Espirito Santo
  • Publication number: 20070009543
    Abstract: The present invention relates to new uses of CDCP1 in the diagnosis, screening, treatment and prophylaxis of ovarian cancer. The invention also provides compositions comprising CDCP1, including vaccines, antibodies that are immunospecific for CDCPI and agents which interact with or modulate the expression or activity of CDCP1 or which modulate the expression of the nucleic acid which codes for CDCP1.
    Type: Application
    Filed: October 22, 2004
    Publication date: January 11, 2007
    Inventor: Nicola Burgess
  • Publication number: 20030083287
    Abstract: The invention provides ginS polypeptides and, polynucleotides encoding ginS polypeptides and methods for producing such polypeptides by recombinant techniques. Also provided are methods for utilizing ginS polypeptides to screen for antibacterial compounds.
    Type: Application
    Filed: November 30, 2001
    Publication date: May 1, 2003
    Inventors: Nicola A. Burgess, Miguel M. Camara Garcia, David F. Kirke, Nicholas L. Meyers, Paul Williams